Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Revenue (2016 - 2025)

Historic Revenue for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $191000.0.

  • Pharma's Revenue fell 5364.08% to $191000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 650.89%. This contributed to the annual value of $1.3 million for FY2025, which is 550.19% down from last year.
  • As of Q3 2025, Pharma's Revenue stood at $191000.0, which was down 5364.08% from $328000.0 recorded in Q2 2025.
  • Over the past 5 years, Pharma's Revenue peaked at $555000.0 during Q2 2023, and registered a low of $56000.0 during Q3 2021.
  • Over the past 5 years, Pharma's median Revenue value was $212000.0 (recorded in 2022), while the average stood at $238157.9.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 8681.51% in 2021, then soared by 26071.43% in 2022.
  • Pharma's Revenue (Quarter) stood at $142000.0 in 2021, then soared by 133.8% to $332000.0 in 2022, then tumbled by 38.55% to $204000.0 in 2023, then increased by 25.98% to $257000.0 in 2024, then decreased by 25.68% to $191000.0 in 2025.
  • Its last three reported values are $191000.0 in Q3 2025, $328000.0 for Q2 2025, and $330000.0 during Q1 2025.